Moshav Almagor, Israel

Gideon Gross

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 71(Granted Patents)


Location History:

  • Korazim, IL (2008)
  • Moshav Almagor, IL (2023)

Company Filing History:


Years Active: 2008-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gideon Gross: Innovator in Immunotherapy

Introduction

Gideon Gross is a prominent inventor based in Moshav Almagor, Israel. He has made significant contributions to the field of immunotherapy, particularly through his innovative patents. With a total of 2 patents, Gross has focused on developing advanced methods for enhancing immune responses against cancer and autoimmune diseases.

Latest Patents

One of Gross's latest patents is the "Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)." This invention provides a method for identifying targets to create iCARs or protective chimeric antigen receptors (pCARs) that can prevent or reduce unwanted activation of effector immune cells. The patent also includes a list of iCAR targets, vectors, and transduced effector immune cells, along with methods for cancer treatment using these transduced cells.

Another significant patent is for "Genetically-engineered MHC molecules." This invention involves DNA molecules that encode a chimeric polypeptide, which includes a component of an MHC molecule that can associate with an endogenous MHC molecule on the cell surface. The invention aims to activate T cells through a signal transduction element, which can be crucial for eliminating harmful T cells and treating conditions like graft rejection and autoimmune diseases.

Career Highlights

Gideon Gross has worked with several companies in the biotechnology sector, including Gavish-Galilee Bio Application Ltd. and Immpact-Bio Ltd. His work in these organizations has contributed to the advancement of immunotherapeutic techniques and applications.

Collaborations

Throughout his career, Gross has collaborated with notable individuals in the field, including Alon Margalit and Will Gibson. These partnerships have further enhanced his research and development efforts in immunotherapy.

Conclusion

Gideon Gross is a key figure in the field of immunotherapy, with innovative patents that have the potential to transform cancer treatment and autoimmune disease management. His contributions reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…